researcher comment: the savoir trial | toni choueiri
Published 4 years ago • 84 plays • Length 4:24Download video MP4
Download video MP3
Similar videos
-
3:12
researcher comment: the fraction-rcc study | toni choueiri
-
2:46
dr. choueiri on results of the savoir trial in met-driven papillary rcc
-
1:46
researcher comment: updated keynote-426 data | elizabeth plimack
-
1:08
kidney cancer expert dr. toni choueiri: the 2022 kidney cancer research summit by kidneycan
-
1:08
dr. choueiri on the biology of the cabosun trial for rcc
-
5:11
thyroid fna cytology - medullary thyroid carcinoma
-
1:16:17
diagnostic cytopathology cases
-
4:57
review of the data of frontline treatment for non-clear cell kidney cancer
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
6:31
toni choueiri:
-
5:35
dr. toni choueiri on clinically impactful new rcc data—practiceupdate's esmo 2016 coverage
-
1:38
kidney cancer research at esmo 2020: toni choueiri, md
-
1:45
dr. choueiri on cabosun trial results for rcc
-
1:44
dr. choueiri on cabosun trial results in rcc
-
1:33
dr. choueiri on the next generation of trials in rcc
-
0:51
dr. choueiri discusses the cantata trial in rcc
-
1:14
dr. choueiri on significance of checkmate-025 study for rcc
-
1:20
flow cytometer at menzies institute for medical research | university of tasmania
-
1:35
dr. toni choueiri on cabozantinib versus everolimus in renal cell carcinoma
-
2:31
toni choueiri, md, describes treatment strategies for 2nd line renal cell carcinoma
-
6:13
dr toni choueiri discusses a phase 2 clinical trial on volitinib in papillary renal cell carcinoma